LIVE WEBINAR Nov. 2, 2022
7:00 – 8:00 PM EST
This CME-certified, MOC-eligible live webinar will provide gastroenterologists and hepatologists with the latest information on how to screen for, diagnose, and risk stratify NASH and how to develop patient-personalized multidisciplinary treatment plans. Clinicians will also learn about novel agents in development for NASH, the clinical trial data supporting their use, and how best to integrate these agents into clinical practice as they become available.
Naim Alkhouri, MD
VP of Academic Affairs, Chief of Transplant Hepatology, Director of the Fatty Liver Program, Arizona Liver Health, Phoenix, AZ
Mitchell Shiffman, MD
Director, Liver Institute of Virginia, Liver Institute of Richmond, Liver Institute of Hampton Roads, Bon Secours Mercy Health, Richmond and Newport News, VA